BriaCell (BCTX) Therapeutics announced that it intends to offer to sell common shares in a best-efforts public offering. ThinkEquity is acting as sole placement agent for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCTX:
- BriaCell Therapeutics trading resumes
- BriaCell Therapeutics trading halted, volatility trading pause
- BriaCell’s Bria-OTS™ Shows Promising Results in Resolving Breast Cancer Lung Metastasis
- BriaCell announces resolution of lung metastasis in patient receiving Bria-OTS
- BriaCell Therapeutics trading halted, news pending